Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 29 10:21AM ET
444.18
Dollar change
-2.70
Percentage change
-0.60
%
IndexNDX, S&P 500 P/E28.82 EPS (ttm)15.41 Insider Own0.27% Shs Outstand257.70M Perf Week0.49%
Market Cap114.62B Forward P/E24.33 EPS next Y18.26 Insider Trans-17.14% Shs Float257.37M Perf Month12.11%
Income4.02B PEG2.30 EPS next Q4.17 Inst Own92.81% Short Float1.46% Perf Quarter4.03%
Sales10.17B P/S11.27 EPS this Y11.54% Inst Trans1.21% Short Ratio3.57 Perf Half Y26.84%
Book/sh71.80 P/B6.19 EPS next Y7.46% ROA18.74% Short Interest3.77M Perf Year34.61%
Cash/sh39.42 P/C11.27 EPS next 5Y12.53% ROE24.38% 52W Range320.01 - 457.66 Perf YTD9.17%
Dividend Est.- P/FCF30.83 EPS past 5Y11.42% ROI20.86% 52W High-2.94% Beta0.41
Dividend TTM- Quick Ratio3.29 Sales past 5Y27.16% Gross Margin86.85% 52W Low38.80% ATR (14)8.14
Dividend Ex-Date- Current Ratio3.50 EPS Y/Y TTM22.70% Oper. Margin40.81% RSI (14)63.91 Volatility1.91% 2.02%
Employees5400 Debt/Eq0.04 Sales Y/Y TTM12.74% Profit Margin39.51% Recom1.97 Target Price466.23
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q56.65% Payout0.00% Rel Volume0.52 Prev Close446.88
Sales Surprise4.24% EPS Surprise16.87% Sales Q/Q14.21% EarningsMay 06 AMC Avg Volume1.06M Price444.18
SMA204.01% SMA507.27% SMA20013.54% Trades Volume95,769 Change-0.60%
Date Action Analyst Rating Change Price Target Change
Apr-11-24Upgrade Evercore ISI In-line → Outperform $438
Feb-15-24Initiated Wolfe Research Outperform $515
Feb-06-24Downgrade Evercore ISI Outperform → In-line $436 → $438
Feb-02-24Downgrade Bernstein Outperform → Mkt Perform
Jan-31-24Downgrade Robert W. Baird Neutral → Underperform $325
Jan-31-24Downgrade Maxim Group Buy → Hold
Jan-24-24Downgrade Canaccord Genuity Hold → Sell $332 → $379
Dec-14-23Reiterated RBC Capital Mkts Sector Perform $347 → $379
May-30-23Initiated William Blair Outperform $382
May-04-23Resumed Piper Sandler Overweight $385
May-26-24 10:15AM
09:45AM
May-25-24 11:10PM
10:00AM
06:47AM
02:41AM Loading…
02:41AM
May-24-24 04:28PM
May-23-24 07:10AM
May-22-24 07:06PM
04:40PM
04:05PM
May-21-24 11:47AM
May-17-24 09:30AM
May-15-24 11:11AM
10:30AM
01:47PM Loading…
May-14-24 01:47PM
10:24AM
09:45AM
05:43AM
03:00AM
May-13-24 02:18PM
May-12-24 02:47PM
12:20PM
May-10-24 03:32PM
12:46PM
May-09-24 04:00PM
01:04AM
May-08-24 12:36PM
09:30AM
05:43AM
04:06PM Loading…
May-07-24 04:06PM
02:21PM
11:24AM
09:50AM
09:44AM
06:30AM
06:29AM
05:45AM
05:45AM
05:41AM
05:41AM
05:41AM
03:08AM
May-06-24 08:45PM
06:33PM
05:42PM
05:10PM
04:59PM
04:38PM
04:17PM
04:15PM
04:11PM
04:01PM
02:30PM
May-05-24 07:00AM
06:55AM
May-04-24 12:00PM
07:38AM
May-03-24 07:01PM
02:18PM
08:45AM
06:15AM
May-02-24 05:50PM
07:15AM
May-01-24 09:15AM
09:00AM
Apr-30-24 05:36AM
Apr-29-24 10:00AM
Apr-28-24 08:45AM
Apr-27-24 05:50AM
Apr-26-24 12:22PM
12:11PM
11:43AM
Apr-25-24 05:50PM
09:45AM
07:00AM
Apr-24-24 05:50AM
Apr-23-24 05:09PM
08:09AM
06:05AM
12:45AM
Apr-22-24 11:10AM
09:03AM
07:16AM
05:52AM
Apr-20-24 09:45AM
06:48AM
Apr-19-24 05:50PM
11:57AM
04:30AM
Apr-18-24 08:30AM
08:00AM
07:00AM
Apr-16-24 06:00PM
09:30AM
Apr-15-24 12:00PM
09:15AM
09:04AM
Apr-13-24 08:47AM
05:29AM
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SACHS BRUCE IDirectorMay 22 '24Option Exercise93.517,073661,39647,073May 24 04:13 PM
SACHS BRUCE IDirectorMay 22 '24Sale448.007,0733,168,70440,000May 24 04:13 PM
Kewalramani ReshmaCEO & PresidentMay 20 '24Sale447.0015,2026,795,294121,374May 22 04:21 PM
Arbuckle Stuart AEVP, COOMay 15 '24Sale430.936929,73449,691May 17 04:24 PM
ALTSHULER DAVIDEVP, Chief Scientific OfficerMay 15 '24Sale430.935423,27025,813May 17 04:22 PM
Sachdev AmitEVP Chief Patient & Ext Af OffMay 15 '24Sale430.933213,79055,325May 17 04:27 PM
Bhatia Sangeeta N.DirectorMay 02 '24Sale402.95467188,1784,435May 03 04:05 PM
Ambrose KristenSVP & Chief Accounting OfficerApr 02 '24Sale419.00240100,5607,500Apr 03 04:02 PM
Arbuckle Stuart AEVP, COOFeb 26 '24Sale425.705,0342,142,97449,691Feb 27 04:37 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 26 '24Sale425.704,2391,804,54225,813Feb 27 04:24 PM
Sachdev AmitEVP Chief Patient & Ext Af OffFeb 26 '24Sale425.703,0041,278,80355,325Feb 27 04:59 PM
Ambrose KristenSVP & Chief Accounting OfficerFeb 26 '24Sale425.70883375,8937,965Feb 27 04:29 PM
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Feb 26 '24Sale425.70883375,89315,972Feb 27 04:44 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Feb 26 '24Sale425.70354150,69855,804Feb 27 05:02 PM
Arbuckle Stuart AEVP, COOFeb 21 '24Sale421.773,6031,519,63759,439Feb 23 04:12 PM
Sachdev AmitEVP Chief Patient & Ext Af OffFeb 21 '24Sale421.773,1911,345,86860,798Feb 23 04:20 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 21 '24Sale421.773,0021,266,15434,022Feb 23 04:10 PM
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Feb 21 '24Sale421.771,201506,54618,509Feb 23 04:16 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Feb 21 '24Sale421.77360151,83759,467Feb 23 04:28 PM
Arbuckle Stuart AEVP, COOFeb 20 '24Sale420.794,8042,021,47563,042Feb 21 04:19 PM
Sachdev AmitEVP Chief Patient & Ext Af OffFeb 20 '24Sale420.794,2541,790,04163,989Feb 21 04:38 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 20 '24Sale420.794,0021,684,00237,024Feb 21 04:13 PM
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Feb 20 '24Sale420.79801337,05319,710Feb 21 04:23 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Feb 20 '24Sale420.79480201,97959,827Feb 21 04:43 PM
LEIDEN JEFFREY MExecutive ChairmanFeb 15 '24Sale419.164,6551,951,19017,896Feb 16 04:07 PM
LEIDEN JEFFREY MExecutive ChairmanFeb 14 '24Sale419.044,3561,825,33822,551Feb 16 04:07 PM
LEIDEN JEFFREY MExecutive ChairmanFeb 13 '24Sale419.13737308,89926,907Feb 14 04:04 PM
Arbuckle Stuart AEVP, COOFeb 12 '24Sale420.244,2951,804,93175,718Feb 13 04:51 PM
Sachdev AmitEVP Chief Patient & Ext Af OffFeb 12 '24Sale420.243,2221,354,01374,364Feb 13 05:15 PM
ALTSHULER DAVIDEVP, Global Research and CSOFeb 12 '24Sale420.243,1451,321,65547,588Feb 13 04:46 PM
LEIDEN JEFFREY MExecutive ChairmanFeb 12 '24Sale419.512,6561,114,20527,644Feb 14 04:04 PM
Biller JonathanEVP and Chief Legal OfficerFeb 12 '24Sale418.771,738727,82218,280Feb 13 04:56 PM
Ambrose KristenSVP & Chief Accounting OfficerFeb 12 '24Sale420.241,374577,4109,676Feb 13 04:48 PM
Atkinson Edward Morrow IIIEVP, Chief Technical Ops. Off.Feb 12 '24Sale420.24913383,67923,137Feb 13 04:54 PM
LEIDEN JEFFREY MExecutive ChairmanJan 08 '24Sale419.076,6482,785,9772,423Jan 10 04:06 PM
WAGNER CHARLES F JREVP & Chief Financial OfficerJan 02 '24Sale405.003,0001,215,00043,693Jan 04 04:17 PM
Kewalramani ReshmaCEO & PresidentDec 15 '23Option Exercise181.8317,1353,115,593125,846Dec 19 04:15 PM
Kewalramani ReshmaCEO & PresidentDec 15 '23Sale407.0017,1356,973,945108,711Dec 19 04:15 PM
Arbuckle Stuart AEVP, COODec 13 '23Option Exercise187.538,6031,613,32165,159Dec 15 04:20 PM
LEIDEN JEFFREY MExecutive ChairmanDec 13 '23Sale399.4213,3545,333,7999,071Dec 15 04:33 PM
Arbuckle Stuart AEVP, COODec 13 '23Sale399.008,6033,432,59756,556Dec 15 04:20 PM
Kewalramani ReshmaCEO & PresidentDec 13 '23Sale397.005,0982,023,906108,711Dec 15 04:23 PM
WAGNER CHARLES F JREVP & Chief Financial OfficerNov 20 '23Sale349.883,0001,049,64046,693Nov 21 04:07 PM
Sachdev AmitEVP Chief Patient & Ext Af OffNov 15 '23Sale369.923512,94758,814Nov 17 04:16 PM
ALTSHULER DAVIDEVP, Global Research and CSONov 15 '23Sale369.92197,02832,038Nov 17 04:11 PM
Bozic CarmenEVP and CMONov 14 '23Sale380.825,6502,151,63329,302Nov 16 04:15 PM
Kewalramani ReshmaCEO & PresidentNov 13 '23Sale377.005,0971,921,569113,809Nov 15 04:16 PM
SACHS BRUCE IDirectorNov 06 '23Option Exercise127.5411,2501,434,82551,250Nov 08 04:11 PM
SACHS BRUCE IDirectorNov 06 '23Sale385.0011,2504,331,25040,000Nov 08 04:11 PM
Bozic CarmenEVP and CMOOct 31 '23Sale355.925,6512,011,30434,952Nov 02 04:07 PM
Bozic CarmenEVP and CMOOct 17 '23Sale373.255,6512,109,23640,603Oct 19 04:18 PM
Bhatia Sangeeta N.DirectorOct 17 '23Sale375.0024391,1253,901Oct 19 04:13 PM
LEIDEN JEFFREY MExecutive ChairmanOct 16 '23Sale374.0012,9624,847,78822,425Oct 18 04:17 PM
Bhatia Sangeeta N.DirectorOct 06 '23Sale360.0024287,1204,144Oct 11 04:14 PM
Bozic CarmenEVP and CMOOct 03 '23Sale345.285,6511,951,17746,254Oct 05 04:30 PM
Biller JonathanEVP and Chief Legal OfficerOct 02 '23Sale346.76610211,52410,569Oct 03 04:07 PM
Bozic CarmenEVP and CMOSep 19 '23Sale351.005,6511,983,50151,905Sep 21 04:15 PM
Bozic CarmenEVP and CMOSep 05 '23Sale352.665,6511,992,88257,556Sep 07 04:29 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Aug 23 '23Sale355.002,500887,50048,637Aug 25 04:14 PM
Kearney Terrence CDirectorAug 10 '23Option Exercise127.5410,0001,275,40016,536Aug 14 04:09 PM
Sachdev AmitEVP, Chief Patient OfficerAug 10 '23Sale350.0010,0313,510,85058,814Aug 14 04:05 PM
Kearney Terrence CDirectorAug 10 '23Sale350.0010,0003,500,0006,536Aug 14 04:09 PM
Tatsis OuraniaEVP, Chief Reg. & Quality Off.Aug 10 '23Sale345.795,7501,988,29351,137Aug 14 04:08 PM
Bhatia Sangeeta N.DirectorAug 09 '23Sale345.5124283,6134,386Aug 11 04:05 PM
ALTSHULER DAVIDEVP, Global Research and CSOAug 09 '23Sale345.516321,76732,038Aug 11 04:05 PM
SACHS BRUCE IDirectorJul 17 '23Option Exercise127.5411,2501,434,82551,250Jul 18 04:17 PM
SACHS BRUCE IDirectorJul 17 '23Sale356.7511,2504,013,45940,000Jul 18 04:17 PM
Kewalramani ReshmaCEO & PresidentJul 17 '23Sale355.007,8282,778,940118,906Jul 18 04:13 PM
Arbuckle Stuart AEVP, COOJun 15 '23Option Exercise187.538,6031,613,32165,159Jun 20 04:07 PM
Arbuckle Stuart AEVP, COOJun 15 '23Sale349.008,6033,002,44756,556Jun 20 04:07 PM
Ambrose KristenSVP & Chief Accounting OfficerMay 30 '23Sale329.8228995,3186,838Jun 01 04:12 PM
Arbuckle Stuart AEVP, COOMay 30 '23Sale329.828227,04556,556Jun 01 04:16 PM